“showed a trend”

Kaplan-Meier analysis also showed a trend of improved survival in mice treated with pevonedistat alone and in combination over the control group (p < 0.05) (Figure 6C ).

The group supplemented with Astragalus dregs showed a trend towards improved ADG and ADFI and reduced diarrhoea rates ( p > 0.05).

Global pRNFL thickness correlated with Hoehn & Yahr stages ( r = − 0.487, p = 0.025), and nasal pRNFL thinning showed a trend of correlation (uncorrected p < 0.05).

Pairwise comparisons showed a trend for a difference between medicated individuals with ADHD and those with MDD ( P =.05; d =0.72; MDiff=11.63, 95% CI –0.08 to 23.34).

Among these behaviors, urination showed a trend more similar to the jumping ( Fig. 2 , Qui-square test for trend, P<0.05).

When ADHD traits at 2 years were included in the model the overall regression was statistically significant ( r 2 = 0.640, F (2,79) = 68.44, p < 0.001), ADHD traits at age 2 significantly predicted ADHD traits at age 3 (β = 0.798, p < 0.001), and Prohibition scores at age 2 showed a trend-level predictive association to ADHD traits at age 3 (β = 0.035, p = 0.050).No other predictive associations from EF performance at 2 years to 3-year autism and ADHD traits were found.

The OS showed a trend that the higher the expression of SLCO1B3, the better the OS ( P < 0.05) (Fig. 1 D1,D2).

EphA2 showed a trend toward being an independent prognostic factor (HR, 2.4; 95% CI, 1.0-5.8; p = 0.050).

In particular, the homozygous 4R genotype demonstrated an association with improved MPH response, when compared with other genotypes (OR: 1.66, 95%CI: 1.16–2.37, P = 0.005), whereas the meta-analysis of the 7R repeat allele versus others showed a trend with an OR = 0.68 (95%CI: 0.47–1.00, P = 0.05) 38 .

Administration at 6 h showed a trend toward longer survival ( p = 0.050), whereas administration at 12 h resulted in shorter survival compared with concurrent treatment (Fig. 5 c).

The effect size for the multiple sclerosis subgroup showed a trend in favor of eHealth interventions (SMD –0.47, 95% CI –0.95 to 0.01, P =.05, I2=63.10%), but was not significant for the cancer group (SMD 0.61, 95% CI –0.36 to 1.58, P =.22).

Our hypothesis was also supported by the finding that CD304, one of the surface antigens of pDC, showed a trend towards higher gene expression levels after incubation in the HC group compared to the placebo group (p=0.05).

The faster the patients were admitted to the hospital, the better was their MVS rating at medical release The time from the injury to admission to the study, when correlated with the MVS T4 , showed a trend of significance ( X 2 (1, N = 41) = 3.6, p = 0.05), wherein 76% (31/41) of the patients admitted to the hospital shortly after the injury obtained a very good evaluation at the medical release in regard to the MVS.

Furthermore, a combination of the TNM staging system and ACCI showed a trend toward higher prognostic value and higher AUC for OS and CSS than the TNM staging system alone (P < 0.05).

The preintervention group showed a trend toward less acute VTE events (39% vs 55%; P = .05).

BOP showed a trend toward reduction in the omega-3 group, although the confidence intervals crossed the null value, and heterogeneity emerged at three months ( p < 0.05) ( Figure 11 A,B).

Mortality Compared to the control group, FCM administration showed a trend towards reduced risk of all-cause death (RR: 0.86, 95% CI: 0.74–1.00, P = .05, Figure 4A ) (absolute risk difference 16 (95% CI 29 to 0) fewer per 1000 patients; moderate certainty) and CV death (RR: 0.86, 95% CI: 0.72–1.02, P = .09, Figure 4B ) (absolute risk difference 12 (95% CI 24 fewer to 2 more) per 1000 patients; moderate certainty) at 1-year follow-up.

The overall model did not yield significant predictors at the p < 0.05 level, although perceived financial support showed a trend-level negative association with anxiety ( β = − 5.59, p = 0.05), indicating that better financial backing may contribute to lower anxiety scores.

764.0, P = 0.011) and showed a trend towards more FIGO stage IV disease (63.3% vs. 40.4%, P = 0.050), compared to those with PDS.

90%; p < 0.05; OR = 2.32; 1.34–4.03; p < 0.05) (Table 3b ) and showed a trend toward higher effectiveness with Triple‐AL (92.5% vs. 86%; p ≈0.05).

Compared with control group, CME significantly (p<0.05) improved the laying rate while DLM and MHA-Ca showed a trend of promotion (p>0.05).

In lymph nodes, only the suspension group showed a trend toward elevated CD4 + Foxp3 + T cells relative to the model group ( p < 0.05). 4.

No significant differences were noted in the UPDRS III motor scores, even though women showed a trend towards having worse bradykinesia ( P = 0.05) and axial motor ( P = 0.07) scores compared to men during ON.

In group 3, the collagen 3 concentration and αSMA-positive cell counts remained high but showed a trend towards decrease when compared to group 2 ( P > 0.05).

Consistent with previous studies, in this study, with the increase of salinity, species abundance showed a trend of decreasing first and then increasing, and the turning point was 5.02 ppt ( p < 0.05) ( Figure 5 a), which was similar with the study in Hau River, Vietnam [ 7 ].